You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 251 No. 16, April 27, 1984 TABLE OF CONTENTS
  JAMA
  •  Online Features
  LETTERS
 This Article
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Counter-Detailing

Wendy Levinson, MD; Patrick M. Dunn, MD
Good Samaritan Hospital and Medical Center Portland, Ore

JAMA. 1984;251(16):2084.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.—

Physicians and medical residents are constantly approached by pharmaceutical representatives who are skilled in marketing their company's products. Some residency programs do not allow the pharmaceutical detailers access to their trainees. The faculty of medicine at our hospital developed a plan that not only allows such an interaction but simultaneously improves the trainee's knowledge of drug therapeutics.

Good Samaritan Hospital and Medical Center is a 539-bed community hospital in Portland, Ore, with a fully accredited internal medicine training program. Pharmacy residents schedule participating drug representatives and the product they wish to detail. Each morning, the medical residents attend a half-hour teaching conference to discuss interesting patient problems. During the last five minutes of this morning report, the pharmacy resident discusses the pharmacokinetics, therapeutic usefulness, and side effects of the drug of the day. A comparison of efficacy, toxicity, and cost of other available drugs in the same . . . [Full Text PDF of this Article]



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1984 American Medical Association. All Rights Reserved.